Nonetheless, larger scale studies are necessary to justify the consideration of MELF pattern invasion as a risk factor for higher-stage disease, lymph node metastasis, and thus poor outcomes in EEA. The gene discussed is EPM2A; the disease is metastatic malignant neoplasm in the lymph nodes.